349 related articles for article (PubMed ID: 30883352)
21. Coding variants in TREM2 increase risk for Alzheimer's disease.
Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
[TBL] [Abstract][Full Text] [Related]
22. Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson's Disease Susceptibility.
Liu G; Liu Y; Jiang Q; Jiang Y; Feng R; Zhang L; Chen Z; Li K; Liu J
Mol Neurobiol; 2016 Sep; 53(7):4931-8. PubMed ID: 26365049
[TBL] [Abstract][Full Text] [Related]
23. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
Mori Y; Yoshino Y; Ochi S; Yamazaki K; Kawabe K; Abe M; Kitano T; Ozaki Y; Yoshida T; Numata S; Mori T; Iga J; Kuroda N; Ohmori T; Ueno S
PLoS One; 2015; 10(9):e0136835. PubMed ID: 26332043
[TBL] [Abstract][Full Text] [Related]
24. Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population.
Miyashita A; Wen Y; Kitamura N; Matsubara E; Kawarabayashi T; Shoji M; Tomita N; Furukawa K; Arai H; Asada T; Harigaya Y; Ikeda M; Amari M; Hanyu H; Higuchi S; Nishizawa M; Suga M; Kawase Y; Akatsu H; Imagawa M; Hamaguchi T; Yamada M; Morihara T; Takeda M; Takao T; Nakata K; Sasaki K; Watanabe K; Nakashima K; Urakami K; Ooya T; Takahashi M; Yuzuriha T; Serikawa K; Yoshimoto S; Nakagawa R; Saito Y; Hatsuta H; Murayama S; Kakita A; Takahashi H; Yamaguchi H; Akazawa K; Kanazawa I; Ihara Y; Ikeuchi T; Kuwano R
J Alzheimers Dis; 2014; 41(4):1031-8. PubMed ID: 24762945
[TBL] [Abstract][Full Text] [Related]
25. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
26. Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson's disease in the Han Chinese population.
Li Z; Zhong L; Gu L; Huang W; Shi X; Zhang X; An X; Lin Q; Tzeng CM
BMJ Open; 2016 Jan; 6(1):e009499. PubMed ID: 26758262
[TBL] [Abstract][Full Text] [Related]
27. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.
Giraldo M; Lopera F; Siniard AL; Corneveaux JJ; Schrauwen I; Carvajal J; Muñoz C; Ramirez-Restrepo M; Gaiteri C; Myers AJ; Caselli RJ; Kosik KS; Reiman EM; Huentelman MJ
Neurobiol Aging; 2013 Aug; 34(8):2077.e11-8. PubMed ID: 23582655
[TBL] [Abstract][Full Text] [Related]
28. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
29. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
Cady J; Koval ED; Benitez BA; Zaidman C; Jockel-Balsarotti J; Allred P; Baloh RH; Ravits J; Simpson E; Appel SH; Pestronk A; Goate AM; Miller TM; Cruchaga C; Harms MB
JAMA Neurol; 2014 Apr; 71(4):449-53. PubMed ID: 24535663
[TBL] [Abstract][Full Text] [Related]
30. Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function.
Dash R; Munni YA; Mitra S; Choi HJ; Jahan SI; Chowdhury A; Jang TJ; Moon IS
Sci Rep; 2022 Jun; 12(1):9378. PubMed ID: 35672339
[TBL] [Abstract][Full Text] [Related]
31. TREM2 rare variant p.R47H is not associated with Parkinson's disease.
Mengel D; Thelen M; Balzer-Geldsetzer M; Söling C; Bach JP; Schaeffer E; Herold C; Becker T; Liepelt I; Becker J; Riedel-Heller S; Scherer M; Jessen F; Maier W; Dodel R; Ramirez A
Parkinsonism Relat Disord; 2016 Feb; 23():109-11. PubMed ID: 26651418
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis.
Siokas V; Aloizou AM; Liampas I; Tsouris Z; Mentis AA; Nasios G; Papadimitriou D; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Mol Biol Rep; 2021 Mar; 48(3):2601-2610. PubMed ID: 33826063
[TBL] [Abstract][Full Text] [Related]
33. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
Varnum MM; Clayton KA; Yoshii-Kitahara A; Yonemoto G; Koro L; Ikezu S; Ikezu T
J Biol Chem; 2017 Jun; 292(25):10651-10663. PubMed ID: 28490631
[TBL] [Abstract][Full Text] [Related]
34. Assessment of TREM2 rs75932628 association with Parkinson's disease and multiple system atrophy in a Chinese population.
Chen Y; Chen X; Guo X; Song W; Cao B; Wei Q; Ou R; Zhao B; Shang HF
Neurol Sci; 2015 Oct; 36(10):1903-6. PubMed ID: 26058955
[TBL] [Abstract][Full Text] [Related]
35. Behavioral Variant Frontotemporal Dementia-like Syndrome With Novel Heterozygous TREM2 Frameshift Mutation.
Williamson JC; Larner AJ
Alzheimer Dis Assoc Disord; 2019; 33(1):75-76. PubMed ID: 30106757
[No Abstract] [Full Text] [Related]
36. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
37. Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of
Ogonowski N; Santamaria-Garcia H; Baez S; Lopez A; Laserna A; Garcia-Cifuentes E; Ayala-Ramirez P; Zarante I; Suarez-Obando F; Reyes P; Kauffman M; Cochran N; Schulte M; Sirkis DW; Spina S; Yokoyama JS; Miller BL; Kosik KS; Matallana D; Ibáñez A
J Med Genet; 2023 Sep; 60(9):894-904. PubMed ID: 36813542
[TBL] [Abstract][Full Text] [Related]
38. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
[TBL] [Abstract][Full Text] [Related]
39. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.
Guerreiro RJ; Lohmann E; Brás JM; Gibbs JR; Rohrer JD; Gurunlian N; Dursun B; Bilgic B; Hanagasi H; Gurvit H; Emre M; Singleton A; Hardy J
JAMA Neurol; 2013 Jan; 70(1):78-84. PubMed ID: 23318515
[TBL] [Abstract][Full Text] [Related]
40. The rs75932628 and rs2234253 polymorphisms of the TREM2 gene were associated with susceptibility to frontotemporal lobar degeneration in Caucasian populations.
Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y
Ann Hum Genet; 2018 Jul; 82(4):177-185. PubMed ID: 29322490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
